Does LEUPROLIDE Cause Gynaecomastia? 363 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 363 reports of Gynaecomastia have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.5% of all adverse event reports for LEUPROLIDE.
363
Reports of Gynaecomastia with LEUPROLIDE
0.5%
of all LEUPROLIDE reports
7
Deaths
49
Hospitalizations
How Dangerous Is Gynaecomastia From LEUPROLIDE?
Of the 363 reports, 7 (1.9%) resulted in death, 49 (13.5%) required hospitalization.
Is Gynaecomastia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 363 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Gynaecomastia?
RISPERIDONE (24,453)
PALIPERIDONE (4,155)
QUETIAPINE (535)
FINASTERIDE (428)
ARIPIPRAZOLE (393)
OLANZAPINE (389)
SPIRONOLACTONE (307)
DIVALPROEX (226)
METHYLPHENIDATE (201)
ENZALUTAMIDE (175)
Which LEUPROLIDE Alternatives Have Lower Gynaecomastia Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM